Archive for the ‘Bartonella’ Category

Dr. Burrascano on Tick-borne Illness Testing

http://  Approx. 15 Min

IGeneX 2021 Presentation Wisconsin Naturopathic Doctors Association (WNDA)

May 10, 2021

See Dr. Joseph Burrascano presenting on behalf of IGeneX Laboratory at the annual WNDA conference. Topics cover testing for Lyme Disease, Tick-Borne Relapsing Fever, Bartonella, Babesia, Rickettsia, Anaplasma, and Ehrlichia.

Dr. Burrascano discusses the Lyme ImmunoBlot test for early Lyme, validated with CDC test samples, that will identify 93% of cases.

He discussed a 2018 study of over 10,000 patient samples from nearly every state which found patients testing positive for the following pathogens:

  • nearly 38% for Babesia
  • 32% for Lyme borrelia
  • nearly 28% for TBRF borrelia
  • 19% for Bartonella
  • nearly 17% for Anaplasma
  • nearly 13% for Rickettsia
  • nearly 7% for Ehrlichia

Further:

  • 40% tested positive for 2 pathogens
  • 15% for 3
  • 4.6% for 4
  • 0.7% for 5

May Lyme Awareness Talk, 2021

http://

May 5, 2021

Lyme Awareness Talk

According the the Centers for Disease Control and Prevention (CDC), the average number of Lyme disease cases has more than doubled over the last decade.  In this presentation, Alicia Cashman from the Madison Lyme Support Group discusses tick-born illness, why it’s so difficult to obtain help, symptoms, prevention, and real life experience of patients.  The program was made possible through funding from the Friends of the Oregon Library.

Slide 1: Lyme Disease a 21st Century Pandemic
Slide 2: Why should we care about Lyme disease:
Slide 3: The History of Lyme disease:
Slide 4:  What is Lyme disease?
  • The CDC/NIH/IDSA accepted narrative
  • Reality
Slide 5: Pleomorphism (Lyme shape-shifts)
Slide 6: Video of a spirochetal cluster grown from a sick patient’s blood
Slide 7: Polymicrobialism (There are often other infections involved)
Slide 8:  How is Lyme Transmitted?
  • The CDC accepted narrative
  • Reality
Slide 9:  Congenital Lyme – is real
Slide 10: How is Lyme diagnosed?
Slide 11:  Symptoms of Lyme disease
  • CDC accepted narrative
  • Reality
Slide 12: Lyme disease signs and symptoms explained by Dr. Aucott of Johns Hopkins
  • Patients can jump to stage 3 quickly and bypass the other stages.  I give the example of the little girl who went out to play, got a tick bite above her eye and within 4-6 hours couldn’t walk or talk.
  • Many never see the tick or the rash
  • While the rash is diagnostic for Lyme (if you have the rash, you have Lyme – no testing required), you may still be infected even if you don’t have the rash. Most doctors are uneducated, don’t know what the rash looks like, and mistakenly tell people they got a spider or other bug bite.  The rash can also be irregular: https://madisonarealymesupportgroup.com/2020/07/18/misdiagnosis-of-lyme-caused-rash-can-have-potentially-fatal-consequences/
Slide 13: Why are definitions important?
  • Organism
  • Transmission
  • Treatment
Slide 14:  Tick Prevention
Slide 15: Willy Burgdorfer, the “discoverer” of Lyme
Slide 16: New Treatments for Lyme disease
Please remember that most patients are infected with numerous infections.  Treatment should reflect this as research shows patients fighting numerous infections simultaneously have more severe symptoms for a much longer duration.
Slide 17: Hollywood Stars infected with Lyme

Reminder: Lyme Awareness Talk – May 4, 2021

https://madisonarealymesupportgroup.com/2021/04/06/lyme-awareness-talk-in-may-lyme-awareness-month/

LYME DISEASE IN WISCONSIN

When: Tuesday, May 4, 2021 – 7:00pm to 8:00pm
Where: Online

For adults held via Zoom. Registration required and opens April 1.

According to the Centers for Disease Control and Prevention, the average number of cases has more than doubled over the last decade. In this presentation, learn from Alicia Cashman from Madison Lyme Support Group about Lyme Disease, how to protect you and your family, what common symptoms are, and what to do if you have symptoms.

If you have questions or need special accommodations at events contact Kara at (608) 835-6268 or kripley@oregonlibrary.org.

The program is made possible through funding from the Friends of the Oregon Library.

Tick on a green plant

PANS, A Misdirected Immune Response, Can Hijack a Child’s Life

https://www.lymedisease.org/brandi-dean-pans-immune/

PANS, a misdirected immune response, can hijack a child’s life

Pilot Study Finds Evidence of Bartonella in Schizophrenia Patients

https://news.ncsu.edu/2021/03/pilot-study-bartonella-schizophrenia-patients/

Pilot Study Finds Evidence of Bartonella Infection in Schizophrenia Patients

NC State gateway at sunset
FOR IMMEDIATE RELEASE

A pilot study from North Carolina State University and the University of North Carolina at Chapel Hill has found evidence of Bartonella infection in the blood of people with schizophrenia and schizoaffective disorder.

“Researchers have been looking at the connection between bacterial infection and neuropsychiatric disease for some time,” says Dr. Erin Lashnits, a former veterinary internist at NC State, current faculty member at the University of Wisconsin and first author of the study.

“Specifically, there has been research suggesting that cat ownership is associated with schizophrenia due to the zoonotic parasite Toxoplasma gondii, but to date there has been no conclusive evidence in support of a causative role for this parasite. So we decided to look at another cat-associated infectious agent, Bartonella, to see if there could be a connection.”

Bartonella are bacteria historically associated with cat-scratch disease, which until recently was thought to be solely a short-lived (or self-limiting) infection. Cats can become infected with Bartonella via exposure to fleas and potentially ticks, which are natural vectors of the bacteria. The cat is a host for at least three of the 40 known Bartonella species: Bartonella henselae, Bartonella clarridgeiae and Bartonella koehlerae.

“While there is emerging understanding of neuropsychiatric illnesses such as schizophrenia as disorders of brain networks, the question about the actual causes remains unanswered,” says corresponding author Flavio Frohlich, associate professor of psychiatry at the UNC School of Medicine. “It was an exciting opportunity for us in the UNC Department of Psychiatry to team up with the leading experts on Bartonella to pursue this innovative idea of a potential link to schizophrenia. To our knowledge, this is the very first work that examines a potential role of Bartonella in schizophrenia.”

The research team enrolled a group of 17 people with stable, medically managed schizophrenia or schizoaffective disorder, and a control group of 13 healthy adults, to test for evidence of Bartonella infection.

All participants filled out questionnaires on severity of symptoms and potential Bartonella exposure. Blood samples were taken from participants twice in a one-week period. The samples were cultured in a growth medium, and both cultured and whole blood samples underwent qPCR and droplet digital, or ddPCR testing, at seven-, 14- and 21-day intervals, to look for evidence of Bartonella organism-specific DNA. Blood samples were also tested for Bartonella species-specific antibodies.

Of the 17 patients with schizophrenia, 12 had Bartonella DNA in their blood, as compared to only one of 13 in the control group. According to the questionnaires, both patients and controls reported similar pet ownership and flea exposures.

Bartonella ddPCR, a very new diagnostic technology, provides a more sensitive molecular test than we’ve previously had access to,” says Dr. Ed Breitschwerdt, Melanie S. Steele Distinguished Professor of Internal Medicine at NC State and study coauthor. “If we had not used ddPCR to test this cohort of individuals, we would not have found Bartonella DNA in any of the participants, either case or control.”

“It is important to remember that our study was by design not able to demonstrate a causal link between Bartonella infection and schizophrenia,” Frohlich says. “However, we believe this initial observational study strongly supports the need for follow-up research.”

The researchers plan to proceed with a larger study to see whether their preliminary results are borne out.

“Many of these patients have been undergoing care for years,” Breitschwerdt says. “What we’re starting to see is a pattern – Bartonella can persist for a long time. And for the subset of people who can’t eliminate the infection, the bacteria can cause chronic or progressive illness.”

The research appears in Vector Borne and Zoonotic Diseases and was supported in part by the National Institutes of Health (grants UL1TR002489 and T32OD011130). Ricardo Maggi and Julie Bradley of NC State, as well as L. Fredrik Jarskog of UNC-Chapel Hill, contributed to the work.

_________________________

Note to editors: The abstract of the paper follows.

“Schizophrenia and Bartonella spp. infection: a pilot case-control study”

DOI: 10.1089/vbz.2020.2729

Authors: Erin Lashnits, Ed Breitschwerdt, Ricardo Maggi, Julie Bradley, North Carolina State Univerity; L. Fredrik Jarskog, Flavio Frolich, University of North Carolina at Chapel Hill
Published: March 15, 2021 in Vector-Borne and Zoonotic Diseases

Abstract:
Recently, infections with emerging zoonotic bacteria of the genus Bartonella have been reported in association with a range of central nervous system (CNS) symptoms. Currently, it remains unknown if Bartonella spp. infection is associated with symptoms of schizophrenia/schizoaffective disorder (SCZ/SAD). The objective of this study was to determine if there is an association between Bartonella species infection and SCZ/SAD. A secondary objective was to determine if SCZ/SAD symptoms were more severe among participants with documented Bartonella spp. infection. Using a case–control study design, 17 cases and 13 controls were evaluated with a series of clinical and cognitive assessments. Blood samples were collected and tested for Bartonella spp. infection using serological, microbiological, and molecular techniques. People with SCZ/SAD were more likely than healthy volunteers to have Bartonella spp. DNA in their bloodstream, with 11 of 17 cases (65%) positive by Bartonella spp. droplet digital PCR (ddPCR). In comparison, only one healthy volunteer was Bartonella spp. ddPCR positive (8%, p = 0.0024). Based on serology, Bartonella spp. exposure was common among people with SCZ/SAD (12 of 17) as well as among healthy volunteers (12 of 13), with no significant difference between the groups ( p = 0.196). Within the case group of people with SCZ/SAD, there was no significant difference in SCZ/SAD severity scores between people with and without ddPCR evidence of Bartonella spp. infection. This pilot study provides preliminary evidence in support of future investigations that should examine a potential contribution of Bartonella spp. infection to SCZ/SAD.

________________________

For more: